Nuwellis Debt to Equity Ratio 2012-2025 | NUWE
Current and historical debt to equity ratio values for Nuwellis (NUWE) over the last 10 years. The debt/equity ratio can be defined as a measure of a company's financial leverage calculated by dividing its long-term debt by stockholders' equity. Nuwellis debt/equity for the three months ending September 30, 2025 was 0.00.
| Nuwellis Debt/Equity Ratio Historical Data | |||
|---|---|---|---|
| Date | Long Term Debt | Shareholder's Equity | Debt to Equity Ratio |
| 2025-09-30 | $0.00B | $0.00B | 1.04 |
| 2025-06-30 | $0.02B | $-0.01B | -2.03 |
| 2025-03-31 | $0.00B | $0.00B | 0.96 |
| 2024-12-31 | $0.00B | $0.01B | 0.51 |
| 2024-09-30 | $0.00B | $0.00B | 1.12 |
| 2024-06-30 | $0.01B | $-0.01B | -1.91 |
| 2024-03-31 | $0.01B | $0.00B | 6.53 |
| 2023-12-31 | $0.01B | $0.00B | 2.04 |
| 2023-09-30 | $0.00B | $0.01B | 0.46 |
| 2023-06-30 | $0.00B | $0.01B | 0.40 |
| 2023-03-31 | $0.01B | $0.01B | 0.35 |
| 2022-12-31 | $0.01B | $0.01B | 1.00 |
| 2022-09-30 | $0.00B | $0.01B | 0.32 |
| 2022-06-30 | $0.00B | $0.02B | 0.25 |
| 2022-03-31 | $0.00B | $0.02B | 0.20 |
| 2021-12-31 | $0.00B | $0.03B | 0.17 |
| 2021-09-30 | $0.00B | $0.03B | 0.14 |
| 2021-06-30 | $0.00B | $0.03B | 0.14 |
| 2021-03-31 | $0.00B | $0.03B | 0.11 |
| 2020-12-31 | $0.00B | $0.02B | 0.23 |
| 2020-09-30 | $0.00B | $0.02B | 0.17 |
| 2020-06-30 | $0.00B | $0.01B | 0.37 |
| 2020-03-31 | $0.00B | $0.01B | 0.30 |
| 2019-12-31 | $0.00B | $0.00B | 1.82 |
| 2019-09-30 | $0.00B | $0.00B | 0.75 |
| 2019-06-30 | $0.00B | $0.01B | 0.36 |
| 2019-03-31 | $0.00B | $0.01B | 0.23 |
| 2018-12-31 | $0.00B | $0.01B | 0.48 |
| 2018-09-30 | $0.00B | $0.01B | 0.22 |
| 2018-06-30 | $0.00B | $0.01B | 0.24 |
| 2018-03-31 | $0.00B | $0.01B | 0.16 |
| 2017-12-31 | $0.00B | $0.02B | 0.14 |
| 2017-09-30 | $0.00B | $0.01B | 0.34 |
| 2017-06-30 | $0.00B | $0.01B | 0.24 |
| 2017-03-31 | $0.00B | $0.00B | 1.03 |
| 2016-12-31 | $0.01B | $0.00B | 2.33 |
| 2016-09-30 | $0.00B | $0.00B | 1.69 |
| 2016-06-30 | $0.01B | $0.00B | 2.52 |
| 2016-03-31 | $0.01B | $0.01B | 1.34 |
| 2015-12-31 | $0.01B | $0.01B | 1.01 |
| 2015-09-30 | $0.01B | $0.02B | 0.59 |
| 2015-06-30 | $0.01B | $0.03B | 0.42 |
| 2015-03-31 | $0.01B | $0.03B | 0.29 |
| 2014-12-31 | $0.00B | $0.03B | 0.11 |
| 2014-09-30 | $0.00B | $0.04B | 0.08 |
| 2014-06-30 | $0.00B | $0.04B | 0.07 |
| 2014-03-31 | $0.00B | $0.05B | 0.06 |
| 2013-12-31 | $0.00B | $0.05B | 0.07 |
| 2013-09-30 | $0.00B | $0.06B | 0.05 |
| 2013-06-30 | $0.00B | $0.02B | 0.11 |
| 2013-03-31 | $0.00B | $0.01B | 0.20 |
| 2012-12-31 | $0.00B | $0.01B | 0.16 |
| 2012-09-30 | $0.00B | $0.02B | 0.14 |
| 2012-06-30 | $0.00B | $0.00B | 3.51 |
| 2012-03-31 | $0.00B | $0.00B | 0.70 |
| 2011-12-31 | $0.00B | $0.01B | 0.62 |
| 2011-09-30 | $0.00B | $0.00B | 0.00 |
| 2011-06-30 | $0.00B | $0.00B | 0.00 |
| 2011-03-31 | $0.00B | $0.00B | 0.00 |
| 2010-12-31 | $0.00B | $0.01B | 0.07 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Instruments Manufacturing | $0.003B | $0.009B |
| Nuwellis Inc. is a medical device company. It is focused on developing, manufacturing and commercializing the Aquadex SmartFlow(R) System for ultrafiltration therapy. Nuwellis Inc., formerly known as CHF Solutions, is headquartered in Minneapolis, Minn. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Thermo Fisher Scientific (TMO) | United States | $233.627B | 27.76 |
| Intuitive Surgical (ISRG) | United States | $196.001B | 76.68 |
| IDEXX Laboratories (IDXX) | United States | $56.733B | 56.34 |
| Edwards Lifesciences (EW) | United States | $48.223B | 32.33 |
| IQVIA Holdings (IQV) | United States | $41.102B | 22.92 |
| Alcon (ALC) | Switzerland | $39.514B | 26.70 |
| Mettler-Toledo (MTD) | United States | $30.348B | 35.51 |
| DexCom (DXCM) | United States | $27.184B | 37.47 |
| STERIS (STE) | Ireland | $25.935B | 26.77 |
| Waters (WAT) | United States | $23.414B | 30.96 |
| Coloplast (CLPBY) | Denmark | $20.103B | 34.31 |
| Hologic (HOLX) | United States | $16.754B | 17.60 |
| SONOVA HOLDING (SONVY) | Switzerland | $16.523B | 0.00 |
| Globus Medical (GMED) | United States | $12.375B | 25.97 |
| Penumbra (PEN) | United States | $12.275B | 86.34 |
| Masimo (MASI) | United States | $7.435B | 23.82 |
| Sysmex ADR (SSMXY) | Japan | $6.351B | 20.18 |
| Glaukos (GKOS) | United States | $5.998B | 0.00 |
| TransMedics (TMDX) | United States | $4.851B | 57.47 |
| Teleflex (TFX) | United States | $4.554B | 7.26 |
| Veracyte (VCYT) | United States | $3.356B | 38.24 |
| LivaNova (LIVN) | United Kingdom | $3.323B | 17.95 |
| Integer Holdings (ITGR) | United States | $2.968B | 13.93 |
| Elekta AB (EKTAY) | Sweden | $2.412B | 22.57 |
| Alphatec Holdings (ATEC) | United States | $2.369B | 0.00 |
| Artivion (AORT) | United States | $2.013B | 92.39 |
| UFP Technologies (UFPT) | United States | $2.009B | 26.53 |
| Nihon Kohden (NHNKY) | Japan | $1.974B | 17.23 |
| PROCEPT BioRobotics (PRCT) | United States | $1.753B | 0.00 |
| AxoGen (AXGN) | United States | $1.421B | 0.00 |
| Tandem Diabetes Care (TNDM) | United States | $1.415B | 0.00 |
| IRadimed (IRMD) | United States | $1.292B | 61.53 |
| OPKO Health (OPK) | United States | $0.998B | 0.00 |
| Integra LifeSciences Holdings (IART) | United States | $0.976B | 5.29 |
| Pulse Biosciences (PLSE) | United States | $0.969B | 0.00 |
| SiBone (SIBN) | United States | $0.757B | 0.00 |
| Beta Bionics (BBNX) | United States | $0.748B | 0.00 |
| Pacific Biosciences Of California (PACB) | United States | $0.713B | 0.00 |
| Tactile Systems Technology (TCMD) | United States | $0.670B | 38.96 |
| Alpha Tau Medical (DRTS) | Israel | $0.636B | 0.00 |
| ORTHOFIX MEDICAL INC (OFIX) | United States | $0.567B | 0.00 |
| NeuroPace (NPCE) | United States | $0.558B | 0.00 |
| AVANOS MEDICAL, INC (AVNS) | United States | $0.551B | 10.99 |
| Mesa Laboratories (MLAB) | United States | $0.479B | 13.22 |
| OrthoPediatrics (KIDS) | United States | $0.462B | 0.00 |
| ClearPoint Neuro (CLPT) | United States | $0.438B | 0.00 |
| AngioDynamics (ANGO) | United States | $0.422B | 0.00 |
| RxSight (RXST) | United States | $0.398B | 0.00 |
| Delcath Systems (DCTH) | United States | $0.367B | 61.06 |
| Sight Sciences (SGHT) | United States | $0.364B | 0.00 |
| Semler Scientific (SMLR) | United States | $0.327B | 2.44 |
| Spectral Diagnostics (EDTXF) | Canada | $0.310B | 0.00 |
| Nano-X Imaging (NNOX) | Israel | $0.197B | 0.00 |
| 908 Devices (MASS) | United States | $0.197B | 0.00 |
| Anteris Technologies Global (AVR) | Australia | $0.186B | 0.00 |
| Inogen (INGN) | United States | $0.176B | 0.00 |
| Treace Medical Concepts (TMCI) | United States | $0.172B | 0.00 |
| Lucid Diagnostics (LUCD) | United States | $0.171B | 0.00 |
| Rapid Micro Biosystems (RPID) | United States | $0.163B | 0.00 |
| CVRx (CVRX) | United States | $0.159B | 0.00 |
| EDAP TMS S.A (EDAP) | France | $0.153B | 0.00 |
| Zomedica (ZOMDF) | United States | $0.151B | 0.00 |
| Microbot Medical (MBOT) | United States | $0.145B | 0.00 |
| Solana (HSDT) | United States | $0.144B | 0.00 |
| LENSAR (LNSR) | United States | $0.142B | 0.00 |
| Neuronetics (STIM) | United States | $0.121B | 0.00 |
| Hyperfine (HYPR) | United States | $0.120B | 0.00 |
| Accuray (ARAY) | United States | $0.095B | 0.00 |
| Sensus Healthcare (SRTS) | United States | $0.082B | 0.00 |
| DarioHealth (DRIO) | United States | $0.080B | 0.00 |
| Atossa Genetics (ATOS) | United States | $0.078B | 0.00 |
| QT Imaging Holdings (QTIH) | United States | $0.068B | 0.00 |
| InspireMD (NSPR) | United States | $0.067B | 0.00 |
| Positron (POSC) | United States | $0.057B | 0.00 |
| Spectral AI (MDAI) | United States | $0.050B | 0.00 |
| Baird Medical Investment Holdings (BDMD) | $0.034B | 0.00 | |
| Precision Optics (POCI) | United States | $0.034B | 0.00 |
| Ekso Bionics Holdings (EKSO) | United States | $0.021B | 0.00 |
| Envoy Medical (COCH) | United States | $0.020B | 0.00 |
| Vicarious Surgical (RBOT) | United States | $0.018B | 0.00 |
| NexGel (NXGL) | United States | $0.014B | 0.00 |
| SINTX TECHNOLOGIES, INC (SINT) | United States | $0.014B | 0.00 |
| Adagio Medical Holdings (ADGM) | United States | $0.014B | 0.00 |
| Check-Cap (MBAI) | Israel | $0.012B | 0.00 |
| Tenon Medical (TNON) | United States | $0.011B | 0.00 |
| PAVmed (PAVM) | United States | $0.009B | 0.00 |
| EnVVeno Medical (NVNO) | United States | $0.007B | 0.00 |
| Nanovibronix (NAOV) | United States | $0.004B | 0.00 |
| Autonomix Medical (AMIX) | United States | $0.004B | 0.00 |
| ENDRA Life Sciences (NDRA) | United States | $0.003B | 0.00 |
| Venus Concept (VERO) | Canada | $0.002B | 0.00 |
| ENvue Medical (FEED) | United States | $0.002B | 0.00 |
| Bluejay Diagnostics (BJDX) | United States | $0.001B | 0.00 |
| WORK Medical Technology Group (WOK) | China | $0.000B | 0.00 |
| Fresenius Medical Care AG KGaA (FMS) | Germany | $0.000B | 10.28 |
| Spinal Elements Holdings (SPEL) | United States | $0.000B | 0.00 |
| Inspira Technologies OXY B.H.N (IINN) | Israel | $0.000B | 0.00 |
| Longview Acquisition II (LGV) | United States | $0.000B | 0.00 |